Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal (GI) diseases.

Register for Details

For more details on financing and valuation for Metacrine, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Metacrine's ticker symbol?


What is Metacrine's stock price?

0.4949 as of 2/8/23

Learn more about Metacrine

Forge green plus iconForge green minus icon

What is Metacrine funding to date?

Metacrine has raised $134.77MM to date.
Forge green plus iconForge green minus icon

When was Metacrine founded?

Metacrine was founded in 2014.
Updated on: Jun 12, 2022